A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer (Q41002117)
Jump to navigation
Jump to search
scientific article published on 4 January 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer |
scientific article published on 4 January 2016 |
Statements
1 reference
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer (English)
1 reference
Masanori Noguchi
1 reference
Fukuko Moriya
1 reference
Noriko Koga
1 reference
Satoko Matsueda
1 reference
Tetsuro Sasada
1 reference
Akira Yamada
1 reference
Tatsuyuki Kakuma
1 reference
Kyogo Itoh
1 reference
4 January 2016
1 reference
1 reference
65
1 reference
2
1 reference
151-160
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference